Paradigm Global Events is again proud to present it’s bi-annual Biosimilars & Follow-On Biologics 2017 Americas congress. In this congress, we will cover a diverse range of topic and address the challenges and obstacle encountered by the industry from development to successful market of biosimilars. This will also offer and provide a unique platform for knowledge sharing and convergence from Pharmaceuticals, Biotechnology, Regulatory and many more.
The FDA’s approval of the first Biosimilar product in the US is a significant event. A full blown Biosimilars market offers a huge potential in bettering patient outcomes and contributing compelling cost, opening the doors for easy access and optimal care. It was reported that Biosimilars could save the US economy up to $250 billion within the next seven years.